{"id":"W7024029596","doi":"","title":"Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update","year":2017,"lang":"en","type":"other","venue":"","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Risk management; Payment; Key (lock)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005969965,0.0004264505,0.0006603794,0.0001411326,0.0001676431,0.00009417016,0.0002530536,0.001376161,0.0008835472],"category_scores_gemma":[0.00009866747,0.0002813272,0.0001144151,0.00003802402,0.0008284475,0.0000441477,0.0001322351,0.0004374115,0.0001804855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001155574,"about_ca_system_score_gemma":0.00007629771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001646649,"about_ca_topic_score_gemma":0.0002277851,"domain_scores_codex":[0.9981806,0.0001984318,0.0004227505,0.0007552843,0.00004624723,0.0003966914],"domain_scores_gemma":[0.9975278,0.00004817993,0.001209651,0.001115139,0.00005039739,0.00004881363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001128267,0.00005352434,0.0001651463,0.00007288811,0.0004330454,0.00008493581,0.00001408511,2.577871e-9,0.002876981,0.0003269744,0.9890133,0.006846297],"study_design_scores_gemma":[0.0006111848,0.0001769395,0.0001564068,0.0002173232,0.0001570183,0.0002476748,0.000008335768,0.000001322924,0.00310766,0.0008355962,0.9940567,0.0004238418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.00002484082,0.01239369,0.0002205499,0.002973898,0.001661386,0.001255888,0.0003503331,0.00032424,0.9807952],"genre_scores_gemma":[0.0003555939,0.001882877,0.003567305,0.0007861962,0.0001316801,0.00002515229,0.0001250732,0.0001380532,0.992988],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01219289,"threshold_uncertainty_score":0.9999639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04871906888237188,"score_gpt":0.3090232978968216,"score_spread":0.2603042290144497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}